KYOTO, Japan, March 01, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2017, pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
Details are as follows:
Details of Share Repurchase
1. Period of own share repurchase: From February 1, 2017 through February 28, 2017
2. Class of shares: Common stock
3. Number of own shares repurchased: 0
4. Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of execution date.
Reference
A) The following details were resolved by the Company’s Board of Directors on January 24, 2017:
1. Class of shares: Common stock
2. Total number of shares that may be repurchased: Up to 5,000,000 shares
(1.69% of total number of shares issued, excluding treasury stock)
3. Total repurchase amount: Up to 50 billion yen
4. Period of repurchase: From January 27, 2017 through January 26, 2018
B) Total number and yen amount of own shares repurchased from January 27, 2017 through February 28, 2017, pursuant to the Board of Directors resolution above:
1. Total number of own shares repurchased: 0
2. Total repurchase amount: 0 yen
Contact: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 [email protected]


Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



